NTLA 内幕交易
NTLA 的 SEC Form 4 内幕交易记录
总交易
41
买入
0
买入总额
-
卖出总额
$1.6M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(30) | LEONARD JOHN M | President and CEO | 卖出 | 2,785 | $13.00 | $36K | 2026-08-21 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LEONARD JOHN M | President and CEO | 卖出 | 19,890 | $12.60 | $251K | 2026-08-20 | CEO卖出, 董事卖出 |
| ★★★★★(28) | DULAC EDWARD J III | EVP, Chief Financial Officer | 卖出 | 8,111 | $11.25 | $91K | 2026-07-22 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(23) | CLARK ELIANA | EVP, Chief Technical Officer | 卖出 | 57,750 | $12.75 | $736K | 2026-10-05 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | DUBE MICHAEL P | VP, Chief Accounting Officer | 卖出 | 1,864 | $12.43 | $23K | 2026-10-02 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | DULAC EDWARD J III | EVP, Chief Financial Officer | 卖出 | 4,677 | $18.00 | $84K | 2026-07-02 | CFO卖出 |
| ★★★★★(18) | DUBE MICHAEL P | VP, Chief Accounting Officer | 卖出 | 2,641 | $16.78 | $44K | 2026-07-01 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | BASTA JAMES | EVP, General Counsel | 卖出 | 1,211 | $13.78 | $17K | 2026-03-02 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | CLARK ELIANA | EVP, Chief Technical Officer | 卖出 | 607 | $13.78 | $8K | 2026-03-02 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(10) | LEONARD JOHN M | - | 卖出 | 22,675 | $12.95 | $294K | 2026-08-20 | 董事卖出 |
| ★★★★★(0) | MARANTZ JING L. | EVP, Chief Medical Officer | 卖出 | 275,061 | - | - | 2026-10-26 | |
| ★★★★★(0) | MARANTZ JING L. | EVP, Chief Medical Officer | 卖出 | 199,822 | - | - | 2026-10-26 | |
| ★★★★★(0) | LEONARD JOHN M | President and CEO | 卖出 | 0 | $12.87 | - | 2026-08-20 | |
| ★★★★★(0) | BHANJI MUNA | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | CHASE WILLIAM J | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | VERWIEL FRANK | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | GOODMAN JESSE | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | GOFF BRIAN | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | KERESTY GEORGIA | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | COHEN FRED E | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | CHASE WILLIAM J | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | VERWIEL FRANK | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | COHEN FRED E | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | GOODMAN JESSE | - | 卖出 | 9,200 | - | - | 2026-06-09 | |
| ★★★★★(0) | KERESTY GEORGIA | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | BHANJI MUNA | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | GOFF BRIAN | - | 卖出 | 13,300 | - | - | 2026-06-09 | |
| ★★★★★(0) | BASTA JAMES | EVP, General Counsel | 卖出 | 46,080 | - | - | 2026-03-01 | |
| ★★★★★(0) | LEBWOHL DAVID | EVP, Chief Medical Officer | 卖出 | 9,943 | - | - | 2026-03-01 | |
| ★★★★★(0) | DUBE MICHAEL P | VP, Chief Accounting Officer | 卖出 | 17,250 | - | - | 2026-03-01 | |
| ★★★★★(0) | LEONARD JOHN M | President and CEO | 卖出 | 156,400 | - | - | 2026-03-01 | |
| ★★★★★(0) | LEONARD JOHN M | President and CEO | 卖出 | 0 | - | - | 2026-03-01 | |
| ★★★★★(0) | LEBWOHL DAVID | EVP, Chief Medical Officer | 卖出 | 14,204 | - | - | 2026-03-01 | |
| ★★★★★(0) | DULAC EDWARD J III | EVP, Chief Financial Officer | 卖出 | 61,280 | - | - | 2026-03-01 | |
| ★★★★★(0) | SCHULTES BIRGIT C | EVP, Chief Scientific Officer | 卖出 | 39,200 | - | - | 2026-03-01 | |
| ★★★★★(0) | LEONARD JOHN M | President and CEO | 卖出 | 225,400 | - | - | 2026-03-01 | |
| ★★★★★(0) | DULAC EDWARD J III | EVP, Chief Financial Officer | 卖出 | 87,543 | - | - | 2026-03-01 | |
| ★★★★★(0) | CLARK ELIANA | EVP, Chief Technical Officer | 卖出 | 7,353 | - | - | 2026-03-01 | |
| ★★★★★(0) | BASTA JAMES | EVP, General Counsel | 卖出 | 65,829 | - | - | 2026-03-01 | |
| ★★★★★(0) | SCHULTES BIRGIT C | EVP, Chief Scientific Officer | 卖出 | 56,000 | - | - | 2026-03-01 | |
| ★★★★★(0) | CLARK ELIANA | EVP, Chief Technical Officer | 卖出 | 10,505 | - | - | 2026-03-01 |